Evidence map›Paper›PMID 27322328›Full record

ReviewGenes2016

Role of Telomerase in the Cardiovascular System.

Mark Zurek, Joachim Altschmied, Stefanie Kohlgrüber, Niloofar Ale-Agha, Judith Haendeler

Open access · goldAbstract readReview
In one paragraph

Review in Genes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 37 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Activating the PGC-1Oxidative medicine and cellular longevity · 2018
    Article
  10. Review
  11. Article
  12. Treating Cancer by Targeting Telomeres and Telomerase.Antioxidants (Basel, Switzerland) · 2017
    Review
  13. Aging: Molecular Pathways and Implications on the Cardiovascular System.Oxidative medicine and cellular longevity · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mark ZurekIUF-Leibniz Research Institute for Environmental Medicine, 40225 Duesseldorf, Germany. mark.zurek@uni-duesseldorf.de.
Joachim AltschmiedIUF-Leibniz Research Institute for Environmental Medicine, 40225 Duesseldorf, Germany. joachim.altschmied@uni-duesseldorf.de.
Stefanie KohlgrüberIUF-Leibniz Research Institute for Environmental Medicine, 40225 Duesseldorf, Germany. stefanie@gonnissen.de.
Niloofar Ale-AghaIUF-Leibniz Research Institute for Environmental Medicine, 40225 Duesseldorf, Germany. niloofar.ale-agha@uni-duesseldorf.de.
Judith HaendelerIUF-Leibniz Research Institute for Environmental Medicine, 40225 Duesseldorf, Germany. juhae001@uni-duesseldorf.de.
Leibniz Institute of Environmental Medicine · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aging is one major risk factor for the incidence of cardiovascular diseases and the development of atherosclerosis. One important enzyme known to be involved in aging processes is Telomerase Reverse Transcriptase (TERT). After the discovery of the enzyme in humans, TERT had initially only been attributed to germ line cells, stem cells and cancer cells. However, over the last few years it has become clear that TERT is also active in cells of the cardiovascular system including cardiac myocytes, endothelial cells, smooth muscle cells and fibroblasts. Interference with the activity of this enzyme greatly contributes to cardiovascular diseases. This review will summarize the findings on the role of TERT in cardiovascular cells. Moreover, recent findings concerning TERT in different mouse models with respect to cardiovascular diseases will be described. Finally, the extranuclear functions of TERT will be covered within this review.

Indexed as

agingcardiovascular cellsTelomerase Reverse Transcriptase

Identifiers

PMID27322328
PMCPMC4929428
OpenAlexW2436556612

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.